| 1 |
25684424 | Synthesis and biological evaluation of 3-phenyl-3-aryl carboxamido propanoic acid derivatives as small molecule inhibitors of retinoic acid 4-hydroxylase (CYP26A1). | 2015 Mar 15 |
1 |
| 2 |
26365710 | Design, synthesis, and biological evaluation of amide imidazole derivatives as novel metabolic enzyme CYP26A1 inhibitors. | 2015 Oct 15 |
1 |
| 3 |
19197536 | Expression of retinoid-regulated genes in lamellar ichthyosis vs. healthy control epidermis: changes after oral treatment with liarozole. | 2009 |
1 |
| 4 |
16458519 | Synthesis and CYP26A1 inhibitory activity of 1-[benzofuran-2-yl-(4-alkyl/aryl-phenyl)-methyl]-1H-triazoles. | 2006 Jun 1 |
1 |
| 5 |
15597402 | Discovery of inhibitors of MCF-7 tumor cell adhesion to endothelial cells and investigation on their mode of action. | 2004 Dec |
2 |
| 6 |
11025452 | Retinol conversion to retinoic acid is impaired in breast cancer cell lines relative to normal cells. | 2000 Nov |
2 |
| 7 |
9716180 | Human retinoic acid (RA) 4-hydroxylase (CYP26) is highly specific for all-trans-RA and can be induced through RA receptors in human breast and colon carcinoma cells. | 1998 Aug |
1 |
| 8 |
8757760 | Liarozole inhibits human epidermal retinoic acid 4-hydroxylase activity and differentially augments human skin responses to retinoic acid and retinol in vivo. | 1996 Aug |
5 |